July 9, 2020 – Two more pharmaceutical companies have issued a recall for a medication used to control high blood sugar in people with Type 2 diabetes because it may contain a carcinogen.
Lupin Pharmaceuticals Inc. issued the recall for all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 1000 mg because “additional analysis revealed that certain tested batches were above the Acceptable Daily Intake Limit for the impurity N-Nitrosodimethylamine (NDMA),” according to a statement posted by the U.S. Food and Drug Administration.
GIVING BACK IN STYLE – April 17, 2024 - “It’s still one day at…
RIDING THE WAVE...CALMLY – April 18, 2024 - “I was 13 years old and…
VIDEO – NEW YORK STORIES – April 23, 2024 - Sara Gettelfinger had steadily…
TRY IT, YOU’LL LIKE IT – April 18, 2024 - The rise in “sober…
AUDIO – SOBER MEN CAN DO THAT – April 4, 2024 - Acting icon…
I’LL BET HE GOES TO GA (not Georgia) – April 13, 2024 -The initial…